EYPT Key Metrics | Stock Alarm Pro

Sign In Create Free Alerts

EyePoint Pharmaceuticals, Inc.EYPTNASDAQ

Loading

Overview Intelligence Charts News Fundamentals Key Metrics Earnings Growth Financials Insiders

Key Metrics

As of 2025• vs 2024

Core Metrics

Market Cap

$1.34B+219.1%

Interest Coverage

7376.79x+170.8%

Per Share

Revenue/Share

$0.43-44.3%

Net Income/Share

$-3.17-36.2%

Operating CF/Share

$-3.28-46.2%

Free CF/Share

$-3.32-43.6%

Cash/Share

$4.18-36.6%

Book Value/Share

$4.18-30.1%

Tangible Book/Share

$4.18-30.1%

Equity/Share

$4.18-30.1%

Interest Debt/Share

$0.28-27.1%

Valuation

Market Cap

$1.34B+219.1%

Enterprise Value

$1.26B+268.1%

P/OCF Ratio

-5.57-67.7%

P/FCF Ratio

-5.50-70.8%

P/TB Ratio

4.37+250.8%

EV/EBITDA

-5.16-95.4%

Profitability

Return on Tangible Assets

Capital Allocation

CapEx/OCF

-1.37%+57.4%

CapEx/Revenue

10.46%+11.7%

CapEx/Depreciation

1.42-46.0%

SBC/Revenue

88.85%+4.6%

Balance Sheet

Net Debt/EBITDA

0.33-44.7%

Interest Coverage

7376.79x+170.8%

Efficiency

Days Sales Outstanding

8 days+47.9%

Days Payables Outstanding

6163 days+434.7%

Days Inventory

320 days+41.3%

Receivables Turnover

48.19x-32.4%

Payables Turnover

0.06x-81.3%

Inventory Turnover

1.14x-29.2%

Special Valuations

Graham Number

--

Graham Net-Net

$3.41-34.0%

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance